TNFSF15 and irritable bowel syndrome: TNFSF15, also known as TL1A, is a potential vascular endothelial cell growth inhibitor [27], and it is related to inflammatory diseases of the gut, such as inflammatory bowel disease (IBD) [28] and irritable bowel syndrome (IBS) [29].